Evidence map›Paper›PMID 32034429›Full record

ArticleCellular and molecular life sciences : CMLS2020

Synaptic mitochondrial dysfunction and septin accumulation are linked to complement-mediated synapse loss in an Alzheimer's disease animal model.

Balázs A Györffy, Vilmos Tóth, György Török, Péter Gulyássy, Réka Á Kovács, Henrietta Vadászi, András Micsonai, Melinda E Tóth, Miklós Sántha, László Homolya and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. SEPT3 as a Potential Molecular Target of Triple-Negative Breast Cancer.International journal of general medicine · 2024
    Article
  15. Review
  16. As a Potential Therapeutic Target, C1q Induces Synapse Loss Via Inflammasome-activating Apoptotic and Mitochondria Impairment Mechanisms in Alzheimer's Disease.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2023
    Review
  17. Article
  18. Omics-based biomarkers discovery for Alzheimer's disease.Cellular and molecular life sciences : CMLS · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Balázs A GyörffyELTE NAP Neuroimmunology Research Group, Department of Biochemistry, Institute of Biology, ELTE Eötvös Loránd University, Budapest, Hungary.
Vilmos TóthLaboratory of Proteomics, Institute of Biology, ELTE Eötvös Loránd University, Budapest, Hungary.
György TörökMolecular Cell Biology Research Group, Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences Centre of Excellence, Budapest, Hungary.
Péter GulyássyMS Proteomics Research Group, Institute of Organic Chemistry, Research Centre for Natural Sciences, Budapest, Hungary.
Réka Á KovácsDepartment of Biochemistry, Institute of Biology, ELTE Eötvös Loránd University, Budapest, Hungary.
Henrietta VadásziDepartment of Biochemistry, Institute of Biology, ELTE Eötvös Loránd University, Budapest, Hungary.
András MicsonaiELTE NAP Neuroimmunology Research Group, Department of Biochemistry, Institute of Biology, ELTE Eötvös Loránd University, Budapest, Hungary.
Melinda E TóthInstitute of Biochemistry, Biological Research Centre, Szeged, Hungary.
Miklós SánthaInstitute of Biochemistry, Biological Research Centre, Szeged, Hungary.
László HomolyaMolecular Cell Biology Research Group, Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences Centre of Excellence, Budapest, Hungary.
László DrahosMS Proteomics Research Group, Institute of Organic Chemistry, Research Centre for Natural Sciences, Budapest, Hungary.
Gábor JuhászLaboratory of Proteomics, Institute of Biology, ELTE Eötvös Loránd University, Budapest, Hungary.
Katalin A KékesiELTE NAP Neuroimmunology Research Group, Department of Biochemistry, Institute of Biology, ELTE Eötvös Loránd University, Budapest, Hungary.
József KardosELTE NAP Neuroimmunology Research Group, Department of Biochemistry, Institute of Biology, ELTE Eötvös Loránd University, Budapest, Hungary. kardos@elte.hu.ORCID http://orcid.org/0000-0002-2135-2932
Eötvös Loránd University · HUHUN-REN Szegedi Biológiai Kutatóközpont · HUInstitute of Organic Chemistry · HUInstitute of Molecular Life Sciences · HUSemmelweis University · HU

Funding

Emberi Eroforrások Minisztériuma Therapeutic Development thematic programmeMagyar Tudományos Akadémia Bolyai János fellowshipNemzeti Kutatási Fejlesztési és Innovációs Hivatal 2017-1.2.1-NKP-2017-00002Nemzeti Kutatási Fejlesztési és Innovációs Hivatal FIEK_16-1-2016-0005Nemzeti Kutatási Fejlesztési és Innovációs Hivatal K120391Nemzeti Kutatási Fejlesztési és Innovációs Hivatal K128123Nemzeti Kutatási Fejlesztési és Innovációs Hivatal KTIA_NAP_13-2-2014-0017Nemzeti Kutatási Fejlesztési és Innovációs Hivatal KTIA_NAP_13-2-2015-0003
6 · The paper itself

Abstract

Synaptic functional disturbances with concomitant synapse loss represent central pathological hallmarks of Alzheimer's disease. Excessive accumulation of cytotoxic amyloid oligomers is widely recognized as a key event that underlies neurodegeneration. Certain complement components are crucial instruments of widespread synapse loss because they can tag synapses with functional impairments leading to their engulfment by microglia. However, an exact understanding of the affected synaptic functions that predispose to complement-mediated synapse elimination is lacking. Therefore, we conducted systematic proteomic examinations on synaptosomes prepared from an amyloidogenic mouse model of Alzheimer's disease (APP/PS1). Synaptic fractions were separated according to the presence of the C1q-tag using fluorescence-activated synaptosome sorting and subjected to proteomic comparisons. The results raised the decline of mitochondrial functions in the C1q-tagged synapses of APP/PS1 mice based on enrichment analyses, which was verified using flow cytometry. Additionally, proteomics results revealed extensive alterations in the level of septin protein family members, which are known to dynamically form highly organized pre- and postsynaptic supramolecular structures, thereby affecting synaptic transmission. High-resolution microscopy investigations demonstrated that synapses with considerable amounts of septin-3 and septin-5 show increased accumulation of C1q in APP/PS1 mice compared to the wild-type ones. Moreover, a strong positive correlation was apparent between synaptic septin-3 levels and C1q deposition as revealed via flow cytometry and confocal microscopy examinations. In sum, our results imply that deterioration of synaptic mitochondrial functions and alterations in the organization of synaptic septins are associated with complement-dependent synapse loss in Alzheimer's disease.

Indexed as

Alzheimer DiseaseAmyloidAmyloidogenic ProteinsAnimalsDisease Models, AnimalGene Expression RegulationHumansMiceMicrogliaMitochondriaOligopeptidesPlaque, AmyloidProteomeSeptinsSynapsesSynaptosomesAmyloidAmyloidogenic ProteinsOligopeptidesProteomePS1 antigenSeptinsAlzheimer’s diseaseComplement C1qFluorescence-activated synaptosome sortingMitochondrial dysfunctionSeptinsSynaptic pruning

Identifiers

PMID32034429
PMCPMC7671981
OpenAlexW3004504485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.